La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Taboola.com a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Taboola.com..

Taboola.com (NASDAQ:TBLA) Azioni, Catena delle Opzioni

Taboola.com

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.

Taboola.com Ltd

News

VERI

Veritone Achieves "Awardable" Status In DoD's P1 Solutions Marketplace, Expanding Access To AI Tools For Defense Data Analysis And Workflow Automation

B of A Securities analyst Ebrahim Poonawala maintains PNC Financial Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) with a Buy and raises the price target from $223 to $226.

Price Target

Analyst Ratings

B of A Securities Maintains Buy on PNC Financial Services Gr, Raises Price Target to $226

Needham analyst Charles Shi reiterates Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) with a Buy and maintains $270 price target.

Reiteration

Needham Reiterates Buy on Taiwan Semiconductor, Maintains $270 Price Target

FLGT

Fulgent Genetics Secures EU CE Mark For FulgentExome And PLM, Expanding Access To 4600-Gene NGS Diagnostic Platform Across Europe

Biotech

General

PRTC

PureTech Founded Entity, Seaport Therapeutics, Doses First Patient In Phase 2b BUOY-1 Study of GlyphAllo For Major Depressive Disorder

B of A Securities analyst Joshua Shanker maintains Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) with a Buy and lowers the price target from $337 to $336.

B of A Securities Maintains Buy on Progressive, Lowers Price Target to $336

Main Street's preliminary estimate of net asset value ("NAV") per share as of June&nbsp;30, 2025 is $32.27 to $32.33, representing an increase of $0.24 to $0.30 per share, or 0.7% to 0.9%, from the NAV per share of $32.03 as of March 31, 2025, with this increase after the impact of the supplemental dividend paid in June 2025 of $0.30 per share. The estimated increase in NAV per share is primarily due to the net fair value increase on the investment portfolio and the accretive impact of equity issuances, partially offset by a decrease due to the issuance of restricted stock. The net fair value increase on the investment portfolio is the result of net fair value increases on the wholly-owned asset manager and the lower middle market ("LMM") investment portfolio, partially offset by net fair value decreases on the private loan and middle market investment portfolios.

MAIN

Main Street's Preliminary Estimate Of NAV Per Share As Of June 30, 2025 Is $32.27 - $32.33, Up 0.7% - 0.9%, From NAV Per Share Of $32.03 As Of March 31, 2025

IMAB

I-Mab Acquires Bridge Health To Secure Full IP Rights For Givastomig, Eliminate Royalties, And Accelerate Development Of CLDN18.2 Cancer Therapy

CLSD

Clearside Says Alternatives Under Consideration Include Sale, License, Monetization And/Or Divestitures

&nbsp;<a href="https://recurrentenergy.com/">Recurrent Energy</a>, a subsidiary of <a href="https://www.canadiansolar.com/">Canadian Solar Inc.</a>&nbsp;("Canadian Solar") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) and a global developer, owner, and operator of solar and energy storage assets, announced today it has closed project financing and tax equity for Blue Moon Solar. U.S. Bank, through its subsidiary U.S. Bancorp Impact Finance, is providing both tax equity and construction financing for the project, totaling $260 million.
Constellation will purchase power and renewable energy certificates produced by the 94 MW energy facility under a power purchase agreement with Recurrent Energy. Located in Harrison County, Kentucky, Blue Moon Solar is currently under construction and expected to reach commercial operation in 2026. Recurrent Energy will own and operate the project after it is energized.

CSIQ

Canadian Solar Subsidiary Recurrent Energy Secures $260M to Build Solar Power Plant in Kentucky

B of A Securities analyst Ebrahim Poonawala maintains First Horizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) with a Buy and raises the price target from $26 to $27.

B of A Securities Maintains Buy on First Horizon, Raises Price Target to $27

FFIV

F5 And MinIO Expand Partnership To Deliver High-Performance, Secure AI Data Pipelines For Edge-To-Factory Workloads Across Industries

Clearside Biomedical  To Explore Full Range Of Strategic Alternatives To Advance Its Suprachoroidal Delivery Platform

Preliminary Estimates of Second Quarter 2025 Results
Main Street's preliminary estimate of second quarter 2025 net investment income ("NII") is $0.98 to $1.00 per share and distributable net investment income ("DNII") is $1.05 to $1.07 per share.(1) The preliminary estimates of NII and DNII include $0.05 to $0.06 per share of NII related federal and state income, excise and other tax expenses.

Main Street Capital Preliminary Estimate Of Q2 Net Investment Income Is $0.98 - $1.00 Per Share And Distributable Net Investment Income Is $1.05 - $1.07 Per Share

BMO Capital analyst Ameet Thakkar downgrades Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) from Outperform to Market Perform and raises the price target from $352 to $400.

Downgrades

BMO Capital Downgrades Quanta Services to Market Perform, Raises Price Target to $400

WIIM

RCKT

Rocket Pharmaceuticals shares are trading higher after the company received FDA Regenerative Medicine Advanced Therapy designation for RP-A601 gene therapy in PKP2-arrhythmogenic cardiomyopathy.

RBLX

Roblox Introduces Suite Of Safety Tools Giving Teens More Control And Parents Greater Transparency

Harrow (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>), a leading North American eyecare pharmaceutical company, today announced that it has entered into a definitive agreement with Samsung Bioepis Co. Ltd. (hereafter "Samsung Bioepis") to secure the exclusive U.S. commercial rights to the ophthalmology biosimilar portfolio of Samsung Bioepis — BYOOVIZ&#xAE; (ranibizumab-nuna), an FDA-approved biosimilar referencing LUCENTISi (ranibizumab), and OPUVIZ&#x2122; (aflibercept-yszy), an FDA-approved biosimilar referencing EYLEAii (aflibercept) — two of the most widely used anti-VEGF therapies for retinal diseases.
BYOOVIZ has been commercialized by Biogen in the U.S. since its initial launch in June 2022. In October 2024, Biogen notified Samsung Bioepis of their decision to terminate the 2019 Development and Commercialization Agreement within the U.S. and Canada. Samsung Bioepis has been closely working with Biogen on the transfer of commercialization rights for BYOOVIZ and OPUVIZ back to Samsung Bioepis in these regions. Harrow will assume full responsibility for commercialization of BYOOVIZ in the U.S. upon completion of the transition of commercial rights from Biogen back to Samsung Bioepis. The transition is expected to be completed by the end of 2025.
This strategic acquisition enhances Harrow's position as the leading full-spectrum ophthalmic pharmaceuticals provider in the U.S., expands its pipeline with high-value biosimilars for sight‑threatening retinal diseases, and reinforces its commitment to delivering value-oriented innovation to the U.S. eyecare market.

HROW

SSNLF

Harrow Secures US Rights to Two Vision-Saving Eye Drug Alternatives From Samsung

Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has introduced a new platform aimed at revolutionizing the workplace with AI technology.
What Happened: Amazon Web Services (AWS) on Wednesday unveiled the Amazon Bedrock AgentCore, a customizable service that allows businesses to create a network of interconnected AI agents. These agents can perform tasks such as data analysis and coding, freeing up human employees to focus on more creative and strategic work, <a href="https://www.semafor.com/article/07/16/2025/amazon-launches-ai-agent-building-platform-for-businesses-to-help-boost-productivity">reported</a> Semafor.
The platform was introduced by Swami Sivasubramanian, the company&#8217;s vice president of agentic AI, at the AWS Summit in New York.
The AI agents can operate in the background for up to eight hours and are compatible with popular MCP and A2A protocols, enabling communication with other agents outside the company.
Deepak Singh, vice president of developer agents and experiences, described AgentCore as a significant step towards the widespread adoption of agentic AI, likening its potential to that of the internet.
See Also: <a href="https://benzinga.com/markets/tech/25/07/46438576/nvidia-is-on-a-march-to-5-trillion-market-capitalization-says-dan-ives-as-he-predicts-bullish-environment-for-tech-and-crypto-very-strong-second-half" target="_blank" rel="noopener">Nvidia Is &#8216;On A March To $5 Trillion&#8217; Market Capitalization, Says Dan Ives As He Predicts Bullish Environment For Tech And Crypto: &#8216;Very Strong Second Half&#8217;</a>
Amazon&#8217;s announcement comes on the heels of similar product launches from rivals like Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, and OpenAI. However, AWS sets itself apart by offering agents that are compatible with any framework or model, not just those within the Bedrock ecosystem.
At the New York event, Amazon also introduced a dashboard for employers to monitor agent performance and a marketplace for developers to buy and sell agents.
Why It Matters: Amazon&#8217;s new platform is the latest in a series of moves by the company to solidify its position in the AI space.
In June, Amazon launched a new team within its consumer R&amp;D division to focus on <a href="https://www.benzinga.com/markets/tech/25/06/45783322/amazon-launches-new-agentic-ai-group-to-boost-robotics-enhance-user-interactions">agentic artificial intelligence</a>. In July, the company unveiled <a href="https://www.benzinga.com/markets/tech/25/07/46342110/amazon-unveils-powerful-new-ai-servers-to-support-nvidias-most-advanced-chips">powerful new AI servers</a> to support Nvidia Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) most advanced chips.
Amazon&#8217;s commitment to AI is further evidenced by its potential <a href="https://www.benzinga.com/markets/tech/25/07/46336890/amazon-may-pour-billions-more-into-anthropic-as-13-8-billion-ai-bet-grows-report">multibillion-dollar investment</a> in Anthropic, a San Francisco-based AI model builder. The company is reportedly considering an additional investment to extend its existing $8 billion commitment.
Price Action: Amazon ended Wednesday at $223.19, down 1.40% and gained slightly to $223.95 in pre-market trading, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://benzinga.com/crypto/cryptocurrency/25/07/46452042/xrp-surges-25-in-1-week-heres-when-it-will-hit-a-new-all-time-high" target="_blank" rel="noopener">XRP Surges 25% In 1 Week: Here&#8217;s When It Will Hit A New All-Time High</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

AMZN

GOOG

GOOGL

MSFT

NVDA

Amazon's Bedrock AgentCore Platform Hints At Future Of Work: AI Agents That Think, Code And Collaborate

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy Designation For RP-A601 Gene Therapy In PKP2-Arrhythmogenic Cardiomyopathy

Press Releases

New Study Reveals Nearly 75% of Performance Marketers Are Experiencing Diminishing Returns on Social Media Ad Spend; Over 50% Expand Into Additional Channels Beyond Social

Taboola to Announce First Quarter 2025 Financial Results on May 7, 2025

Taboola Expands Partnership with Gannett to Bolster Realize Offering, Empowering Performance Advertisers to Connect with Consumers Across Entirety of Gannett Properties

Taboola Partners with Samsung to Power News Recommendations on More Samsung Devices Globally

Earnings

Taboola Reports Strong Q1 2025 Financial Results; Results Above High-End of Guidance Across All Key Metrics

Taboola to Participate in Upcoming Investor Conferences

Taboola Launches Predictive Audiences As Part of Realize Offering, Empowering Advertisers to Reach More High-Converting Customers; Advertisers Including The Motley Fool and NerdWallet Achieve Nearly 270% Uplift in Conversions and Drive Incremental Growth, Increase Investment for Realize by Around 40%

Taboola Unveils DeeperDive, a Gen AI Answer Engine Built for the Open Web, Connecting Readers with Unique Publisher Content, Empowering Publishers to Defy Abuse by Gen AI Search

Taboola to Announce Second Quarter 2025 Financial Results on August 6, 2025

TBLA

Angi

Autohome Inc. American Depositary Shares, each representing four class A ordinary shares.

Autohome

Bumble

CarGurus

Cars.com

Trump Media & Technology Group Corp. - Warrants

Trump Media & Tech Gr

EverQuote

FuboTV

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings

JOYY

Nextdoor Holdings, Inc. Class A Common Stock

Nextdoor Holdings

MediaAlpha

Hello Group Inc. - American Depositary Shares

Hello Gr

QuinStreet

Rumble

Shutterstock

Tripadvisor

Vimeo

Vtex

Weibo Corporation - American Depositary Shares

Weibo

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Comments

Taboola.com

Taboola.com (TBLA) Opzioni

Taboola.com (NASDAQ:TBLA) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO